Vimarsana
Biggest News Aggregation in the World

Chief Technologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Chief Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Chief Technologies Today - Breaking & Trending Today

Steakholder Foods : Eat meat sustainably. Be a Steakholder - Form 6-K -Today at 05:18 pm - Vimarsana News

Steakholder Foods : Eat meat sustainably. Be a Steakholder - Form 6-K -Today at 05:18 pm

Eat meat sustainably. Be a Steakholder. September 6, 2023 Dear Shareholder, You are cordially...

PsiQuantum opens UK-based R&D site for high-power cryogenic systems - Vimarsana News

PsiQuantum opens UK-based R&D site for high-power cryogenic systems

Californian quantum computing firm PsiQuantum has opened a UK-based advanced research and development (R&D) site to develop the ‘next generation’ of high-power cryogenic modules to scale photonic quantum computers to millions of qubits.

SciSparc Signs Clinical Trial Agreement with Yale University to Conduct its Phase IIb Trial in Tourette Syndrome - Vimarsana News

SciSparc Signs Clinical Trial Agreement with Yale University to Conduct its Phase IIb Trial in Tourette Syndrome

01.08.2022 - The addition of a U.S. site will allow SciSparc to accelerate trial recruitment and further development of novel treatments for patients in need TEL AVIV, Israel, Aug. 01, 2022 (GLOBE NEWSWIRE) - SciSparc Ltd. (Nasdaq: SPRC) ('Company' or ... Seite 1

SciSparc Announces Expanding its Clinical Operations to Include a U.S. Site Towards its Phase IIb Trial with its Proprietary SCI-110 for the Treatment of Tourette Syndrome - Vimarsana News

SciSparc Announces Expanding its Clinical Operations to Include a U.S. Site Towards its Phase IIb Trial with its Proprietary SCI-110 for the Treatment of Tourette Syndrome

08.07.2022 - TEL AVIV, Israel, July 08, 2022 (GLOBE NEWSWIRE) - SciSparc Ltd. (Nasdaq: SPRC) ('Company' or 'SciSparc'), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, ... Seite 1

SciSparc Announces Expanding its Clinical Operations to - Vimarsana News

SciSparc Announces Expanding its Clinical Operations to

TEL AVIV, Israel, July 08, 2022 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical...